CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Peer comparison-based Risk Communication (PRICOM)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06837428
NCT06837428N/ACompleted

Peer Comparison-based Risk Communication (PRICOM): A Study Protocol to Evaluate the Feasibility of Delivering a Risk Communication Intervention in the Primary Care Setting for Adults With Type 2 Diabetes Mellitus

SingHealth Polyclinics·interventional·Posted Feb 20, 2025·Updated Feb 20, 2025

In Brief

A clinical study evaluating Peer comparison-based Risk Communication (PRICOM) for Diabetes Type 2. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The study objective is to evaluate the feasibility of delivering a risk communication intervention, Peer comparison-based Risk Communication (PRICOM), in the primary care setting for adults with poor T2DM control. Findings from the study will inform further revisions to PRICOM and provide an estimated effect size to estimate the required sample size for a multi-site trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Type 2
CountriesSingapore
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 20, 2025
Enrollment StartAug 21, 2023
Primary CompletionJan 22, 2024
Study CompletionAug 29, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.4 years ago

Interventions

Peer comparison-based Risk Communication (PRICOM)other

Based on the Health Belief Model, a risk communication intervention, Peer comparison-based Risk Communication (PRICOM), was developed for primary care physicians to counsel patients with T2DM on their glycaemic control and the complications that could arise, and to recommend ways to improve glycaemic control and prevent complications (or further complications). This will be supported by information from an AI (Artificial Intelligence) based diabetes tool. PRICOM aims to promote health actions in patients with T2DM by increasing their risk perceptions of diabetes complications.